Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
performed single-cell RNA sequencing of the NG neurons, morphological characterization, and behavioural analysis in mice to generate a map of the NG neurons that innervate the stomach and intestine 7
Research published in Frontiers in Endocrinology found that GLP-1 receptor agonists can improve liver health in people with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD)
It also plays a key role in supporting our immunity and elevating energy levels
These findings were further supported by Nicolau et al 5 , who demonstrated similar clinical improvements in a broader cohort with extended follow-up, thereby reinforcing the potential use of GLP-1 RAs even in patients without metabolic comorbidities
Because it does not suppress appetite, it can theoretically be combined with GLP-1 agonists to add a lipolytic component to the appetite suppression mechanism, though clinical data on this combination is lacking
We analyze the profile of the GLP-1 consumer in 2026 and how their grocery choices are impacting the industry
